Literature DB >> 11721629

Development of new T-vectors containing the luciferase gene. Easy application for direct cloning of a promoter DNA.

C Jo1, B Kang, S A Jo.   

Abstract

For promoter analyses of genes, it is usually necessary to amplify promoter DNA fragments by polymerase chain reaction (PCR) and clone them into a plasmid containing a reporter gene. In the present study we developed a novel plasmid, pGL2-X, which was constructed through a simple procedure of cloning an XcmI cassette from the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) gene into the multicloning site of pGL2-Basic (Promega) pGL2-X was then converted by XcmI digestion into a T-vector which was named pGL2-T. Unfortunately, however, the firefly luciferase gene in pGL2-Basic contains one XcmI restriction site and therefore one base within the recognition site was silent-mutated. The cloning efficiency of the pGL2-T vector was approximately 63% when tested with a PCR product amplified from a promoter region (-501(-)+24) of the murine acetylcholine receptor delta subunit (AchR delta) gene. In C2C12 muscle cells transiently transfected with pGL2-T containing the AchR delta promoter, transcription of the silent-mutated luciferase gene increased 2.2-fold by neuregulin (EGF domain of heregulin beta 1; 100 ng/mL), a known stimulator of AchR delta expression. This result suggested that the pGL2-T vector was biologically functional. Thus, the present study provides an easy method to construct a variety of T-vectors containing different reporter genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11721629     DOI: 10.1385/MB:19:3:331

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN: 1073-6085            Impact factor:   2.695


  12 in total

1.  XcmI site-containing vector for direct cloning and in vitro transcription of PCR product.

Authors:  N Arashi-Heese; M Miwa; H Shibata
Journal:  Mol Biotechnol       Date:  1999-10       Impact factor: 2.695

2.  A universal method for the direct cloning of PCR amplified nucleic acid.

Authors:  D A Mead; N K Pey; C Herrnstadt; R A Marcil; L M Smith
Journal:  Biotechnology (N Y)       Date:  1991-07

3.  A simple and efficient method for direct cloning of PCR products using ddT-tailed vectors.

Authors:  T A Holton; M W Graham
Journal:  Nucleic Acids Res       Date:  1991-03-11       Impact factor: 16.971

4.  General method for direct cloning of DNA fragments generated by the polymerase chain reaction.

Authors:  D Kovalic; J H Kwak; B Weisblum
Journal:  Nucleic Acids Res       Date:  1991-08-25       Impact factor: 16.971

5.  pUCPCR1. A vector for direct cloning of PCR products in a double Xcm1 restriction site offering compatible single 3'-overhanging T residues.

Authors:  E de Vries
Journal:  Mol Biotechnol       Date:  1998-12       Impact factor: 2.695

6.  XcmI-containing vector for direct cloning of PCR products.

Authors:  A Y Borovkov; M I Rivkin
Journal:  Biotechniques       Date:  1997-05       Impact factor: 1.993

7.  A simple method to construct T-vectors using XcmI cassettes amplified by nonspecific PCR.

Authors:  C Jo; S A Jo
Journal:  Plasmid       Date:  2001-01       Impact factor: 3.466

8.  Construction of new T vectors for direct cloning of PCR products.

Authors:  Y Ichihara; Y Kurosawa
Journal:  Gene       Date:  1993-08-16       Impact factor: 3.688

9.  New vectors for direct cloning of PCR products.

Authors:  J Cha; W Bishai; S Chandrasegaran
Journal:  Gene       Date:  1993-12-22       Impact factor: 3.688

10.  Neuregulins are concentrated at nerve-muscle synapses and activate ACh-receptor gene expression.

Authors:  S A Jo; X Zhu; M A Marchionni; S J Burden
Journal:  Nature       Date:  1995-01-12       Impact factor: 49.962

View more
  1 in total

1.  Characterization of the regulatory region of the dopa decarboxylase gene in Medaka: an in vivo green fluorescent protein reporter assay combined with a simple TA-cloning method.

Authors:  Kazuhiro E Fujimori
Journal:  Mol Biotechnol       Date:  2008-11-06       Impact factor: 2.695

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.